bpc-157 human clinical evidence safety regulatory status trials review BPC-157 bpc-157 human clinical trials evidence
Description
Quicker fat loss: Accelerate the weight loss process
doi: 10.1021/acschembio.9b00211
TB-500 considerations: Animal studies found TB-500 could accelerate dormant tumor growth and affect immune responses
Rubino D, et al
(5) Legal and athletic restrictions: The World Anti-Doping Agency (WADA) and most sports organizations prohibit the use of performance-enhancing peptides
- People with significant liver disease (the 9-month monkey toxicology study showed dose-dependent periportal vacuolation in hepatocytes that the FDA flagged as a possible safety signal)
